Alexandrea Colangelo
Family · Johnston, RINPI 1417722323
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,632, more than ten times the $49 reported in 2023. Among family clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 151 payments — averaging $21.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$443
- GSK$321
- AbbVie$283
- Actelion Pharmaceuticals US, Inc.$212
- Exact Sciences$191
- Pfizer$181
- plus $2K from 27 others
What the payments were for
- Food & beverage$3,224100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 21 | $443 |
| GSK | 20 | $321 |
| AbbVie | 14 | $283 |
| Actelion Pharmaceuticals US, Inc. | 7 | $212 |
| Exact Sciences | 8 | $191 |
| Pfizer | 8 | $181 |
| Novartis | 7 | $165 |
| Amgen | 6 | $140 |
| Phathom Pharmaceuticals, Inc. | 6 | $130 |
| Novo Nordisk | 5 | $123 |
| Lundbeck LLC | 6 | $117 |
| Antares Pharma, Inc. | 4 | $85 |
| Vanda Pharmaceuticals Inc. | 3 | $75 |
| Johnson & Johnson | 4 | $67 |
| Harmony Biosciences LLC | 2 | $66 |
| Verona Pharma, Inc. | 3 | $65 |
| Tolmar, Inc. | 4 | $59 |
| E.r. Squibb & Sons, L.L.C. | 2 | $53 |
| Inspire Medical Systems, Inc. | 3 | $52 |
| Medicomp Inc | 1 | $49 |
| Mylan Specialty L.p. | 2 | $41 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| Shield Therapeutics Inc | 2 | $39 |
| Alnylam Pharmaceuticals Inc. | 2 | $30 |
| Dexcom, Inc. | 1 | $30 |
| Mallinckrodt Hospital Products Inc. | 1 | $27 |
| Eisai Inc. | 1 | $25 |
| Boehringer Ingelheim | 1 | $25 |
| Baxter Healthcare | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Grifols USA, LLC | 1 | $19 |
| Bayer | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
How this compares
$3,224 in reported general payments places this provider in the 90th percentile of 457 family providers in Rhode Island.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 21 | $22,024 |
| OzempicSemaglutide | 12 | $11,284 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $10,247 |
| EntrestoSacubitril/Valsartan | 11 | $2,727 |
| Fluticasone Propionate | 66 | $1,171 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 32 | $908 |
| Ventolin HfaAlbuterol Sulfate | 15 | $840 |
| Atorvastatin Calcium | 112 | $811 |
| Omeprazole | 30 | $608 |
| Lisinopril | 74 | $579 |
| Losartan Potassium | 31 | $439 |
| Levothyroxine Sodium | 53 | $402 |
| Ibuprofen | 22 | $351 |
| Rosuvastatin Calcium | 25 | $280 |
| Amlodipine Besylate | 43 | $269 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $25 | $22,02421 claims |
| Novo NordiskOzempic | $123 | $11,28412 claims |
| GSKTrelegy Ellipta | $321 | $10,24716 claims |
| NovartisEntresto | $165 | $2,72711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 457 family providers in Rhode Island.
Other family in Johnston
- Kaleigh RapozaJohnston$14K
- Laura FishpawJohnston$4K
- Meaghan BergeronJohnston$3K
- Carol RobinsonWarwick$82K
- Mark ClarkeSmithfield$37K
- Olga FedorenkoCoventry$24K
- Alicia VatterWarwick$15K
- David RamosRiverside$14K
- Sharon BensonNorth Smithfield$12K
- Michelle Blade MelloWest Warwick$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.